We are live on ! Find out more
ACIU icon

AC Immune

28 hedge funds and large institutions have $45.5M invested in AC Immune in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 5

0.06% less ownership

Funds ownership: 19.17%19.11% (-0.06%)

3% less call options, than puts

Call options by funds: $170K | Put options by funds: $176K

4% less capital invested

Capital invested by funds: $47.4M → $45.5M (-$1.83M)

10% less funds holding

Funds holding: 3128 (-3)

50% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 6

Holders
28
Holders Change
-3
Holders Change %
-9.68%
% of All Funds
0.44%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
8
Reduced
5
Closed
6
Calls
$170K
Puts
$176K
Net Calls
-$6K
Net Calls Change
-$722K
Name Holding Trade Value Shares
Change
Change in
Stake
SFCL
26
Strengthening Families & Communities LLC
Massachusetts
$1K
Simplex Trading
27
Simplex Trading
Illinois
$1K +$1.68K +553 New
Qube Research & Technologies (QRT)
28
Qube Research & Technologies (QRT)
United Kingdom
$530 +$566 +186 New
State Street
29
State Street
Massachusetts
-$167K -56,369 Closed
Millennium Management
30
Millennium Management
New York
-$152K -51,532 Closed
Two Sigma Investments
31
Two Sigma Investments
New York
-$45.1K -15,279 Closed
Squarepoint
32
Squarepoint
New York
-$32.6K -11,036 Closed
FIA
33
FNY Investment Advisers
New York
-$7K -2,625 Closed
GWS
34
Glassman Wealth Services
Virginia
-$77 -26 Closed

ACIU Hedge Fund Activity: Q3 2023 in Review

28 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in AC Immune (ACIU) for Q3 2023, worth a combined $45.5M — down 3.9% from $47.4M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of ACIU and 3 opened new positions — a net loss of 3 holders — while 5 trimmed existing stakes and 8 added.

The largest buyer was Avidity Partners Management, adding an estimated $203K. The largest seller was State Street, exiting entirely with an estimated $167K sold.

  • 28 institutional investors held AC Immune (ACIU) as of Q3 2023, down from 31 in Q2 2023.
  • Funds reported $45.5M of AC Immune stock for Q3 2023, down 3.9% quarter-over-quarter.
  • 3 funds opened new AC Immune positions in Q3 2023 and 6 closed out, a net change of -3 holders.
  • The largest AC Immune buyer in Q3 2023 was Avidity Partners Management, an estimated $203K added.
  • The largest AC Immune seller in Q3 2023 was State Street, an estimated $167K sold.

Based on aggregated 13F filings for Q3 2023.